Reijers et al. 2022 “Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.” JAMA Surg 157: 335-342 PMID:35138335 Surgical Staff: Andrew Spillane van Akkooi et al. 2022 “Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).” Ann Surg Oncol 29: 3694-3708 PMID:35089452 Surgical Staff: Andrew Spillane Newell et al. 2022 “Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.” Cancer Cell 40: 88-102.e7 PMID:34951955 Surgical Staff: Andrew Spillane Scolyer et al. 2022 “BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.” Pathology 54: 6-19 PMID:34937664 Surgical Staff: Andrew Spillane Liyanage et al. 2022 “Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous Melanoma.” J Invest Dermatol 142: 1607-1616 PMID:34813871 Surgical Staff: Andrew Spillane Dempsey et al. 2022 “The role of breast reconstruction choice on body image patient-reported outcomes at four years post-mastectomy for breast cancer: A longitudinal prospective cohort study.” Psychooncology 31: 54-61 PMID:34498358 Surgical Staff: Kylie Snook, Andrew Spillane Crook et al. 2022 “The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.” Fam Cancer 21: 241-253 PMID:33963463 Surgical Staff: Katrina Moore
2021
Downs et al. 2021 “A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.” J Surg Oncol 124: 1544-1550 PMID:34406652 Surgical Staff: Andrew Spillane Aivazian et al. 2021 “Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival.” Mod Pathol 34: 2091 PMID:34349230 Surgical Staff: Andrew Spillane Li et al. 2021 “Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.” Ann Surg Oncol 28: 6109-6123 PMID:34347220 Surgical Staff: Andrew Spillane Aivazian et al. 2021 “Histological regression in melanoma: impact on sentinel lymph node status and survival.” Mod Pathol 34: 1999-2008 PMID:34247192 Surgical Staff: Andrew Spillane Ch'ng et al. 2021 “Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.” Eur J Cancer 153: 8-15 PMID:34126335 Surgical Staff: Andrew Spillane Rawson et al. 2021 “Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.” Ann Oncol 32: 766-777 PMID:33744385 Surgical Staff: Andrew Spillane Thompson et al. 2021 “Treatment of in-transit melanoma metastases using intralesional PV-10.” Melanoma Res 31: 232-241 PMID:33741814 Surgical Staff: Andrew Spillane Menzies et al. 2021 “Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).” Nat Med 27: 301-309 PMID:33558722 Surgical Staff: Andrew Spillane Rozeman et al. 2021 “Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.” Nat Med 27: 256-263 PMID:33558721 Surgical Staff: Andrew Spillane Abd El-Aziz et al. 2021 “Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers.” Biosci Rep 41: 2 PMID:33543229 Surgical Staff: Andrew Spillane Maw et al. 2021 “Case Report of 18F-FDG PET/CT Features of Polyacrylamide Hydrogel Mammoplasty.” Clin Nucl Med 46: e206-e207 PMID:33208622 Surgical Staff: Samriti Sood
7
Made with FlippingBook - professional solution for displaying marketing and sales documents online